Hydroquinone (HQ) is a phenolic compound used in industry processes. We aim to demonstrate a rapid and simple procedure for the determination of HQ. This work has developed two techniques, including colorimetric and electrochemical sensors on paper-based devices. Firstly, we have developed the colorimetric detection for the rapid screening test of HQ using 1.5% 4-(dimethylamino) benzaldehyde with alkaline condition (5 M NaOH). Under suitable conditions, the calibration curve between the intensity and HQ concentration was in the range of 50-500 mg L-1. Then, we developed a multi-walled carbon nanotube/graphene oxide/copper/palladium/platinum (MWCNT/GO/Cu/Pd/Pt) onto a screen-printed carbon electrode (SPCE). The optimal amount of MWCNT/GO/Cu/Pd/Pt nanomaterial is 2 mg for HQ detection. The linear concentration range was found in the range 1 to 20 mg L-1 and a detection limit was found to be 0.40 mg L-1 (3.6 µM) for HQ. Moreover, the proposed device can be applied to determine HQ in real samples and is inexpensive technique, portable, and low consumer time.

Melasma is a prevalent dermatological challenge with limited therapeutic interventions. Platelet-rich plasma (PRP) has been increasingly explored for its potential benefits in various dermatological conditions. This study aimed to systematically review the efficacy and safety of PRP in the treatment of melasma. A comprehensive search in line with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines was executed in January 2024 using PubMed, focusing on studies investigating the efficacy and safety of PRP in melasma. Criteria for inclusion were clinical trials and controlled studies examining PRP\'s role in melasma treatment, while exclusions covered reviews, non-English articles, and studies older than 10 years, among others. Eight studies were included, with the majority targeting female participants. The research displayed consistent positive outcomes, whether PRP was used alone or synergistically with treatments like hydroquinone and tranexamic acid. However, positive studies with the combination of PRP and other drugs will not provide the actual safety and efficacy data of PRP. The combined treatment approaches often showed enhanced results. Satisfaction rates among patients and reductions in the melasma area and severity index (MASI) scores were common findings across the studies, emphasizing the potential of PRP in melasma management. In conclusion, PRP emerges as a promising therapeutic intervention for melasma. Whether as a standalone treatment or combined with established methods, PRP presents significant potential in melasma\'s clinical management, warranting further expansive trials to substantiate its long-term efficacy and safety.

Post inflammatory hyperpigmentation (PIH) affects all skin types with a heightened predilection for darker skin tones. Its course is chronic once developed and treatment is often difficult. This systematic review aims to summarize the treatment outcomes for PIH with a focus on skin of colour (SOC) individuals. A literature search was conducted using MEDLINE (from 1946), Embase (from 1974), PubMed, and Cochrane in adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guideline. Results from 48 studies summarized 1356 SOC individuals. The mean age was 29 years (n = 1036) and 78% were female (n = 786). The ethnic prevalence was 70% Black, 27% Asian, and 3% Latin. Overall, 20% were Fitzpatrick skin type (FST) III, 40% FST IV, 34% FST V, and 6% FST VI. Most cases were precipitated by inflammatory conditions (89%) and localized to the face (83%). The most frequently reported interventions were topical retinoids (22%) and laser therapy (17%). Partial improvement was seen in 85% and 66% of participants, respectively. Laser was the only intervention that offered complete resolution in a subgroup of patients (26%); however, there were reported cases of PIH exacerbation following treatment. Chemical peels (9%) and hydroquinone (7%) were among other treatments with less effective outcomes. PIH and its persistence is a prevalent issue, significantly affecting many affected individuals with darker skin tones. Our results show a lack of robust efficacy across all treatment modalities. There is considerable room for improvement in interventions for at-risk populations.

暂无摘要。

UNASSIGNED: Response to the current available treatments of melasma, dermal type, in particular, is usually gradual and can result in possible side effects.
UNASSIGNED: In this study, we aim to evaluate the efficacy of the combination of plasma rich in growth factors (PRGF) and topical 4% hydroquinone (HQ) in comparison with monotherapy using topical 4% HQ alone in the treatment of dermal type of melasma.
UNASSIGNED: This is a single-blinded, randomized, split-face clinical trial on twenty female patients with dermal type of melasma. Patients were asked to apply topical 4% HQ on both sides of their face at night for 6 months. In each participant, one side of the face was randomly chosen to receive monthly intradermal injections of PRGF for 3 sessions. Efficacy of the treatment was assessed using hemi melasma area and severity index (MASI) score, physician\'s global assessment (PGA), and patients\' global assessment (PtGA).
UNASSIGNED: Both groups revealed significant improvement in hemi-MASI score during the treatment course. Mean percentage of improvement at the end of study was 40.38 ± 6.04% and 33.42 ± 3.23% in the combination therapy and monotherapy groups, respectively (P = 0.31). PGA demonstrated excellent-to-marked improvement in melasma in 25% and 5% of patients in the combination therapy and monotherapy groups, respectively (P = 0.31). PtGA showed high levels of satisfaction in 15% of patients in the combination therapy group (vs. 0% in the monotherapy group) (P = 0.05).
UNASSIGNED: Differences between the two treatment groups in terms of hemi-MASI and PGA scores were not statistically significant; however, patients demonstrated higher satisfaction with combination of PRGF and topical 4% HQ compared with topical HQ alone. Thereby, combination of PRGF and topical 4% HQ can be suggested as a safe alternative therapeutic approach and may hold promise in the development of future therapeutic options for dermal type of melasma.

A novel photoelectrochemical (PEC) sensor was developed for the ultra-sensitive and highly selective detection of hydroquinone (HQ), featuring a composite structure that combines 0D CdS nanoparticles with a 3D flower-like ZnIn2S4 microsphere. The sensor, termed rMIP/CdS/ZnIn2S4, employed molecularly imprinted polymers (MIPs) to achieve specific recognition of HQ. An p-phenylenediamine (pPD) polymer film was electrochemically polymerized onto the surface of the CdS/ZnIn2S4 composite-coated glassy carbon electrode (GCE). Through hydrogen bonding, HQ molecules were imprinted onto the polymer film. Subsequent elution removed these molecules, leaving behind specific recognition sites, enabling selective detection of HQ. The unique spatial structure and heterojunction properties of the 0D CdS nanoparticle/3D flower-like ZnIn2S4 composite, combined with molecular imprinting, significantly enhanced the photocurrent response and increased the selectivity and sensitivity for HQ detection. Under optimal conditions, the rMIP/CdS/ZnIn2S4 sensor demonstrated a low detection limit (0.7 nmol·L-1, S/N=3) over a wide linear range of 1-1200 nmol·L-1. The sensor was successfully applied to detect HQ in real water samples, showing promise for environmental pollution control applications.

Hydroquinone (HQ) is one of benzene metabolites that can cause oxidative stress damage and Homologous recombination repair (HR). A good deal of reactive oxygen species (ROS) generated by oxidative stress can trigger apoptotic signaling pathways. The nuclear factor erythroid 2-related factor 2 (Nrf2) can regulate the cell response to oxidative stress damage. The aim of this study was to explore whether Nrf2 participate in HQ-induced apoptosis and its mechanism. The findings displayed that HQ triggered HR, promoted Nrf2 transfer into the cell nucleus and induced cell apoptosis, while Nrf2 deficient elevated cell apoptosis, attenuated the expression of PARP1 and RAD51. We also observed that Nrf2 deficient triggered Caspase-9. Thus, we speculated that Nrf2 might participate in HQ-induced cell apoptosis through Caspase-9 dependent pathways. Meanwhile, Nrf2 participated in HQ-induced DNA damage repair by regulating the level of PARP1 and RAD51.

Hydroquinone (HQ) in wastewater is of great concern, as it is harmful to human health and threatens the ecological environment. However, the existing adsorbents have low adsorption capacity for HQ. To improve the removal of HQ, N,S-codoped activated carbon-ZIF-67 (NSAC-ZIF-67@C) was synthesized in this study by in situ growth of ZIF-67 on N,S-codoped activated carbon (NSAC) and carbonization. The influence of pH, contact time, and initial concentration on the adsorption behaviors of NSAC-ZIF-67@C on HQ were investigated. Owing to the synergistic effect of abundant active sites and well-developed pore structure, the NSAC-ZIF-67@C achieved a prominent adsorption capacity of 962 mg·g-1 and can still retain high adsorption performance after 5 cycles for HQ, which is superior to that of reported other adsorbents. HQ adsorption follows the pseudo-second-order kinetics model (R2 = 0.99999) and the Freundlich isotherm model. X-ray photoelectron spectroscopy (XPS) analysis before and after adsorption as well as density functional theory (DFT) calculation results showed that pyridinic-N-termini were conducive to the π-π interactions and hydrogen-bonding interactions. Therefore, the adsorption mechanisms of NSAC-ZIF-67@C on HQ involve pore filling, electrostatic attraction, π-π interaction, and hydrogen bonding. This study is expected to provide a reference for designing highly effective adsorbents for wastewater treatment.

α-arbutin has important applications in cosmetics and medicine. However, the extraction yield from plant tissues is relatively low, which restricts its application value. In this study, we investigated the synthesis of α-arbutin using maltodextrin as the donor and hydroquinone as the acceptor, using a cyclodextrin glucosyltransferase (CGTase) from Anaerobranca gottschalkii. We performed site-saturated and site-directed mutagenesis on AgCGTase. The activity of the variant AgCGTase-F235G-N166H was 3.48 times higher than that of the wild type. Moreover, we achieved a conversion rate of 63% by optimizing the reaction pH, temperature, and hydroquinone addition amount. Overall, this study successfully constructed a strain with improved conversion rate for the synthetic production of α-arbutin and hydroquinone. These findings have significant implications for reducing the industrial production cost of α-arbutin and enhancing the conversion rate of the product.

Dihydrobenzofuran is an important skeleton for bioactive compounds and natural products. Hydroquinones can be easily modified into substituted hydroquinones, which effectively undergo oxidation to produce the corresponding benzoquinone derivatives. Benzoquinones are reactive electrophiles that are frequently utilized in coupling with olefins to dihydrobenzofurans. Herein, we report the one-pot oxidative coupling of hydroquinones bearing an electron-withdrawing group at the C2 position with olefins to dihydrobenzofurans in the presence of the Lewis acidic FeCl3 and 2,3-dichloro-5,6-dicyano-p-benzoquinone (DDQ) oxidant. Furthermore, this method was applied to the oxidative coupling of N-electron-withdrawing group-substituted 4-aminophenol.